Latest Drug Approvals news
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
posted February 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
posted January 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
posted January 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Estimated Glucose Disposal Rate Inversely Linked to Benign Prostatic Hyperplasia 
Men 50 Years and Older Seem to Have Insufficient Knowledge Toward BPH 
Telesurgery Feasible for Urological Robotic Operations Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
